Athenex Inc. [NASDAQ: ATNX] loss -6.02% or -0.74 points to close at $11.55 with a heavy trading volume of 2153607 shares. The company report on December 15, 2020 that Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis.
— Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp.
— Actinic keratosis is the second most common diagnosis made by dermatologists in the United States1.
It opened the trading session at $12.70, the shares rose to $12.90 and dropped to $11.43, the range by which the price of stock traded the whole day. The daily chart for ATNX points out that the company has recorded -10.40% loss over the past six months. However, it is still -105.15% lower than its most recent low trading price.
If we look at the average trading volume of 640.05K shares, ATNX reached to a volume of 2153607 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Athenex Inc. [ATNX]:
SVB Leerink have made an estimate for Athenex Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 26, 2020. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $29 to $31. The new note on the price target was released on June 25, 2019, representing the official price target for Athenex Inc. stock. Previously, the target price had yet another raise to $20, while Oppenheimer analysts kept a Outperform rating on ATNX stock.
The Average True Range (ATR) for Athenex Inc. is set at 0.77, with the Price to Sales ratio for ATNX stock in the period of the last 12 months amounting to 7.02. The Price to Book ratio for the last quarter was 4.28, with the Price to Cash per share for the same quarter was set at 2.40.
Trading performance analysis for ATNX stock
Athenex Inc. [ATNX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.97. With this latest performance, ATNX shares dropped by -7.23% in over the last four-week period, additionally sinking by -10.40% over the last 6 months – not to mention a drop of -14.89% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATNX stock in for the last two-week period is set at 39.21, with the RSI for the last a single of trading hit 34.84, and the three-weeks RSI is set at 42.52 for Athenex Inc. [ATNX]. The present Moving Average for the last 50 days of trading for this stock 12.48, while it was recorded at 11.87 for the last single week of trading, and 11.34 for the last 200 days.
Athenex Inc. [ATNX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Athenex Inc. [ATNX] shares currently have an operating margin of -117.88 and a Gross Margin at +31.23. Athenex Inc.’s Net Margin is presently recorded at -122.25.
Return on Total Capital for ATNX is now -57.47, given the latest momentum, and Return on Invested Capital for the company is -57.11. Return on Equity for this stock declined to -75.55, with Return on Assets sitting at -45.60. When it comes to the capital structure of this company, Athenex Inc. [ATNX] has a Total Debt to Total Equity ratio set at 33.94. Additionally, ATNX Total Debt to Total Capital is recorded at 25.34, with Total Debt to Total Assets ending up at 20.55. Long-Term Debt to Equity for the company is recorded at 31.87, with the Long-Term Debt to Total Capital now at 23.79.
Reflecting on the efficiency of the workforce at the company, Athenex Inc. [ATNX] managed to generate an average of -$215,591 per employee. Receivables Turnover for the company is 4.56 with a Total Asset Turnover recorded at a value of 0.37.Athenex Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.40 and a Current Ratio set at 4.90.
Athenex Inc. [ATNX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Athenex Inc. posted -0.28/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 9.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ATNX.
An analysis of insider ownership at Athenex Inc. [ATNX]
There are presently around $618 million, or 58.50% of ATNX stock, in the hands of institutional investors. The top three institutional holders of ATNX stocks are: PERCEPTIVE ADVISORS LLC with ownership of 13,532,467, which is approximately 17.342% of the company’s market cap and around 7.00% of the total institutional ownership; BLACKROCK INC., holding 5,205,137 shares of the stock with an approximate value of $60.12 million in ATNX stocks shares; and ORBIMED ADVISORS LLC, currently with $45.95 million in ATNX stock with ownership of nearly -0.783% of the company’s market capitalization.
Positions in Athenex Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 73 institutional holders increased their position in Athenex Inc. [NASDAQ:ATNX] by around 10,670,633 shares. Additionally, 59 investors decreased positions by around 2,953,332 shares, while 12 investors held positions by with 39,849,774 shares. The mentioned changes placed institutional holdings at 53,473,739 shares, according to the latest SEC report filing. ATNX stock had 40 new institutional investments in for a total of 6,096,599 shares, while 11 institutional investors sold positions of 663,799 shares during the same period.